Shire Settles Patent Battle With Par Unit Over ADHD Drug
A Shire PLC subsidiary settled patent infringement claims Thursday against a Par Pharmaceutical Co. unit and TWi Pharmaceuticals Inc. over their plans to market a generic version of Shire's attention deficit...To view the full article, register now.
Already a subscriber? Click here to view full article